Effects of dihydroergotamine on hemodynamic molsidomine actions in anesthetized dogs.
In pentobarbital-anesthetized mongrel dogs the intravenous actions of 0.50 mg/kg molsidomine on pulmonary artery and left ventricular (LV) end-diastolic pressures and internal heart dimensions (preload), left ventricular systolic and peripheral blood pressures, and total peripheral resistance (afterload), as well as on heart rate, dP/dt, stroke volume, and cardiac output (heart performance) were studied for 2 h. Hemodynamic molsidomine effects were influenced by increasing amounts of intravenously infused dihydroergotamine solution (DHE, 1-64 micrograms X kg-1 X min-1). Molsidomine decreased preload, stroke volume, and cardiac output for over 2 h but decreased ventricular and peripheral pressures for 45 min. Systemic vascular resistance showed a tendency to decrease while heart rate and LV dP/dtmax were not altered. DHE infusion reversed molsidomine effects on the preload and afterload of the heart. The diminished stroke volume was elevated so that cardiac output also increased. Total peripheral resistance increased while heart rate fell in a dose-dependent fashion. The LV dP/dtmax remained unchanged until the highest dose of 64 micrograms X kg-1 X min-1 DHE elevated the isovolumic myocardial contractility. These experiments indicate that DHE can reverse the intravenous molsidomine effects on hemodynamics. Most likely, this is mediated through peripheral vasoconstriction of venous capacitance vessels, thereby affecting molsidomine's action on postcapillary beds of the circulation.
D000758:Anesthesia; D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000503:physiopathology; D004087:Dihydroergotamine / Q000494:pharmacology*; D004285:Dogs; D004347:Drug Interactions; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D008981:Molsidomine; D010069:Oxadiazoles / Q000494:pharmacology*; D013318:Stroke Volume / Q000187:drug effects; D013558:Sydnones / Q000494:pharmacology*; D013997:Time Factors
D010069:Oxadiazoles; D013558:Sydnones; D004087:Dihydroergotamine; D008981:Molsidomine